Executive Briefing: State of Science in the Second Half of 2025

A rising tide of macro dynamics, coupled with widespread economic anxiety, is creating a complex new reality for the life science industry. To understand how scientists are navigating these challenges, we surveyed 450 researchers and leaders across the industry. The results reveal a scientific community concerned about declining public trust and bracing for a recession. Yet, our data uncovers a critical gap between perception and reality, with many budgetary fears based on anticipation rather than actual cuts.

Scientists are responding by aggressively seeking new collaborations for funding and re-evaluating technology adoption, creating a split in purchasing behavior. These dynamics, while challenging, create clear opportunities for suppliers. From the push for automation to a surprising split between long-term AI strategy and near-term sequencing purchases, new avenues for partnership are emerging. This executive briefing as well as the full report highlight how the current political and economic climate shapes scientists’ priorities, how the divergent needs of academia and biopharma are impacting purchasing decisions, and what suppliers can do to build trust and succeed in H2 2025.

Note: Your report will be delivered via email with a one-time download link. Pricing is for an individual license to download/view the PDF report.

For institutional access, please contact hello@thelinusgroup.com.